Shanghai Pharma in largest 2011 Hong Kong IPO so far

    | BY

    clpstaff &clp articles

    The H-share listing of Shanghai Pharmaceuticals Holdings (Shanghai Pharma) has raised US$2 billion on the Hong Kong Stock Exchange. At the time of writing,…

    The H-share listing of Shanghai Pharmaceuticals Holdings (Shanghai Pharma) has raised US$2 billion on the Hong Kong Stock Exchange. At the time of writing, this stands as the largest initial public offering in Hong Kong this year.

    The issuer is a vertically-integrated manufacturer and distributor of pharmaceuticals, and is China's second-largest drug distributor. It has numerous research, manufacturing, distribution and retail outlets.

    This premium content is reserved for
    China Law & Practice Subscribers.

    • A database of over 3,000 essential documents including key PRC legislation translated into English
    • A choice of newsletters to alert you to changes affecting your business including sector specific updates
    • Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
    For enterprise-wide or corporate enquiries, please contact our experienced Sales Professionals at +44 (0)203 868 7546 or [email protected]